<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39456843</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>26</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>28</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1422-0067</ISSN><JournalIssue CitedMedium="Internet"><Volume>25</Volume><Issue>20</Issue><PubDate><Year>2024</Year><Month>Oct</Month><Day>15</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>Variants rs3804099 and rs3804100 in the <i>TLR2</i> Gene Induce Different Profiles of TLR-2 Expression and Cytokines in Response to Spike of SARS-CoV-2.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">11063</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms252011063</ELocationID><Abstract><AbstractText>The present study aimed to identify in patients with severe COVID-19 and acute respiratory distress syndrome (ARDS) the association between rs3804099 and rs3804100 (<i>TLR2</i>) and evaluate the expression of TLR-2 on the cell surface of innate and adaptive cells of patients' carriers of C allele in at least one genetic variant. We genotyped 1018 patients with COVID-19 and ARDS. According to genotype, a subgroup of 12 patients was selected to stimulate peripheral blood mononuclear cells (PBMCs) with spike and LPS + spike. We evaluated soluble molecules in cell culture supernatants. The C allele in <i>TLR2</i> (rs3804099, rs3804100) is not associated with a risk of severe COVID-19; however, the presence of the C allele (rs3804099 or rs3804100) affects the TLR-2 ability to respond to a spike of SARS-CoV-2 correctly. The reference group (genotype TT) downregulated the frequency of non-switched TLR-2+ B cells in response to spike stimulus; however, the allele's C carriers group is unable to induce this regulation, but they produce high levels of IL-10, IL-6, and TNF-α by an independent pathway of TLR-2. Findings showed that TT genotypes (rs3804099 and rs3804100) affect the non-switched TLR-2+ B cell distribution. Genotype TT (rs3804099 and rs3804100) affects the TLR-2's ability to respond to a spike of SARS-CoV-2. However, the C allele had increased IL-10, IL-6, and TNF-α by stimulation with spike and LPS.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Flores-González</LastName><ForeName>Julio</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0003-4707-718X</Identifier><AffiliationInfo><Affiliation>Laboratory of Integrative Immunology, Instituto Nacional de Enfermedades Respiratorias Ismael Cosio Villegas, Mexico City 14080, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Monroy-Rodríguez</LastName><ForeName>Zurisadai</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>HLA Laboratory, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Mexico City 14080, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Falfán-Valencia</LastName><ForeName>Ramcés</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0001-6877-8124</Identifier><AffiliationInfo><Affiliation>HLA Laboratory, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Mexico City 14080, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Buendía-Roldán</LastName><ForeName>Ivette</ForeName><Initials>I</Initials><Identifier Source="ORCID">0000-0002-2825-506X</Identifier><AffiliationInfo><Affiliation>Translational Research Laboratory on Aging and Pulmonary Fibrosis, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Mexico City 14080, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fricke-Galindo</LastName><ForeName>Ingrid</ForeName><Initials>I</Initials><Identifier Source="ORCID">0000-0003-2132-1076</Identifier><AffiliationInfo><Affiliation>HLA Laboratory, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Mexico City 14080, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hernández-Zenteno</LastName><ForeName>Rafael</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>COPD Clinic, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Mexico City 14080, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Herrera-Sicairos</LastName><ForeName>Ricardo</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Laboratory of Integrative Immunology, Instituto Nacional de Enfermedades Respiratorias Ismael Cosio Villegas, Mexico City 14080, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chávez-Galán</LastName><ForeName>Leslie</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0002-2334-0361</Identifier><AffiliationInfo><Affiliation>Laboratory of Integrative Immunology, Instituto Nacional de Enfermedades Respiratorias Ismael Cosio Villegas, Mexico City 14080, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pérez-Rubio</LastName><ForeName>Gloria</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0002-6876-1012</Identifier><AffiliationInfo><Affiliation>HLA Laboratory, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Mexico City 14080, Mexico.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D051195">Toll-Like Receptor 2</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C495342">TLR2 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D064370">Spike Glycoprotein, Coronavirus</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000657845">spike protein, SARS-CoV-2</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016207">Cytokines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051195" MajorTopicYN="Y">Toll-Like Receptor 2</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D064370" MajorTopicYN="Y">Spike Glycoprotein, Coronavirus</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016207" MajorTopicYN="Y">Cytokines</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005838" MajorTopicYN="N">Genotype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012128" MajorTopicYN="N">Respiratory Distress Syndrome</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020641" MajorTopicYN="N">Polymorphism, Single Nucleotide</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000483" MajorTopicYN="N">Alleles</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007963" MajorTopicYN="N">Leukocytes, Mononuclear</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">TLR-2</Keyword><Keyword MajorTopicYN="N">genetic variants</Keyword><Keyword MajorTopicYN="N">rs3804100</Keyword><Keyword MajorTopicYN="N">rs380499</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>9</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>10</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>10</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>26</Day><Hour>19</Hour><Minute>25</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>26</Day><Hour>19</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>26</Day><Hour>1</Hour><Minute>5</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>15</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39456843</ArticleId><ArticleId IdType="pmc">PMC11507191</ArticleId><ArticleId IdType="doi">10.3390/ijms252011063</ArticleId><ArticleId IdType="pii">ijms252011063</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Jackson C.B., Farzan M., Chen B., Choe H. Mechanisms of SARS-CoV-2 entry into cells. Nat. Rev. Mol. Cell Biol. 2022;23:3–20. doi: 10.1038/s41580-021-00418-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41580-021-00418-x</ArticleId><ArticleId IdType="pmc">PMC8491763</ArticleId><ArticleId IdType="pubmed">34611326</ArticleId></ArticleIdList></Reference><Reference><Citation>Tali S.H.S., LeBlanc J.J., Sadiq Z., Oyewunmi O.D., Camargo C., Nikpour B., Armanfard N., Sagan S.M., Jahanshahi-Anbuhi S. Tools and techniques for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)/COVID-19 detection. Clin. Microbiol. Rev. 2021;34:e00228-20. doi: 10.1128/cmr.00228-20.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/cmr.00228-20</ArticleId><ArticleId IdType="pmc">PMC8142517</ArticleId><ArticleId IdType="pubmed">33980687</ArticleId></ArticleIdList></Reference><Reference><Citation>V’Kovski P., Kratzel A., Steiner S., Stalder H., Thiel V. Coronavirus biology and replication: Implications for SARS-CoV-2. Nat. Rev. Microbiol. 2020;19:155–170. doi: 10.1038/s41579-020-00468-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-020-00468-6</ArticleId><ArticleId IdType="pmc">PMC7592455</ArticleId><ArticleId IdType="pubmed">33116300</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng M., Karki R., Williams E.P., Yang D., Fitzpatrick E., Vogel P., Jonsson C.B., Kanneganti T.-D. TLR2 senses the SARS-CoV-2 envelope protein to produce inflammatory cytokines. Nat. Immunol. 2021;22:829–838. doi: 10.1038/s41590-021-00937-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-021-00937-x</ArticleId><ArticleId IdType="pmc">PMC8882317</ArticleId><ArticleId IdType="pubmed">33963333</ArticleId></ArticleIdList></Reference><Reference><Citation>Dai J., Wang Y., Wang H., Gao Z., Wang Y., Fang M., Shi S., Zhang P., Wang H., Su Y., et al. Toll-Like Receptor Signaling in Severe Acute Respiratory Syndrome Coronavirus 2-Induced Innate Immune Responses and the Potential Application Value of Toll-Like Receptor Immunomodulators in Patients with Coronavirus Disease 2019. Front. Microbiol. 2022;13:948770. doi: 10.3389/fmicb.2022.948770.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2022.948770</ArticleId><ArticleId IdType="pmc">PMC9271922</ArticleId><ArticleId IdType="pubmed">35832809</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan S., Shafiei M.S., Longoria C., Schoggins J.W., Savani R.C., Zaki H., States U. SARS-CoV-2 spike protein induces inflammation via TLR2-dependent activation of the NF-κB pathway. eLife. 2021;10:e68563. doi: 10.7554/eLife.68563.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.68563</ArticleId><ArticleId IdType="pmc">PMC8709575</ArticleId><ArticleId IdType="pubmed">34866574</ArticleId></ArticleIdList></Reference><Reference><Citation>Meliț L.E., Mărginean C.O., Săsăran M.O., Mocanu S., Ghiga D.V., Crișan A., Bănescu C. Innate Immune Responses in Pediatric Patients with Gastritis—A Trademark of Infection or Chronic Inflammation? Children. 2022;9:121. doi: 10.3390/children9020121.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/children9020121</ArticleId><ArticleId IdType="pmc">PMC8870386</ArticleId><ArticleId IdType="pubmed">35204842</ArticleId></ArticleIdList></Reference><Reference><Citation>Semlali A., Parine N.R., Al-Numair N.S., Almutairi M., Hawsawi Y.M., Al Amri A., Aljebreen A.M., Arafah M., Almadi M., Azzam N.A., et al. Potential role of toll-like receptor 2 expression and polymorphisms in colon cancer susceptibility in the Saudi Arabian population. OncoTargets Ther. 2018;11:8127–8141. doi: 10.2147/OTT.S168478.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/OTT.S168478</ArticleId><ArticleId IdType="pmc">PMC6241690</ArticleId><ArticleId IdType="pubmed">30532554</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang J., Hu R., Hou S., Ye Z., Xiang Q., Qi J., Zhou Y., Kijlstra A., Yang P. Association of TLR2 gene polymorphisms with ocular Behcet’s disease in a Chinese Han population. Investig. Opthalmology Vis. Sci. 2013;54:8384–8392. doi: 10.1167/iovs.13-12878.</Citation><ArticleIdList><ArticleId IdType="doi">10.1167/iovs.13-12878</ArticleId><ArticleId IdType="pubmed">24255044</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang F., Gao X.-D., Wu W.-W., Gao Y., Zhang Y.-W., Wang S.-P. Polymorphisms in toll-like receptors 2, 4 and 5 are associated with Legionella pneumophila infection. Infection. 2013;41:941–948. doi: 10.1007/s15010-013-0444-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s15010-013-0444-9</ArticleId><ArticleId IdType="pubmed">23526294</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang Y.-K., Wu J.-Q., Zhao H.-Z., Wang X., Wang R.-Y., Zhou L.-H., Yip C.-W., Huang L.-P., Cheng J.-H., Chen Y.-H., et al. Genetic influence of Toll-like receptors on non-HIV cryptococcal meningitis: An observational cohort study. EBioMedicine. 2018;37:401–409. doi: 10.1016/j.ebiom.2018.10.045.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2018.10.045</ArticleId><ArticleId IdType="pmc">PMC6284510</ArticleId><ArticleId IdType="pubmed">30366814</ArticleId></ArticleIdList></Reference><Reference><Citation>Santana N.d.L., Rêgo J.L., Oliveira J.M., de Almeida L.F., Braz M., Machado L.M.M., Machado P.R.L., Castellucci L.C. Polymorphisms in genes TLR1, 2 and 4 are associated with differential cytokine and chemokine serum production in patients with leprosy. Mem. Inst. Oswaldo Cruz. 2017;112:260–268. doi: 10.1590/0074-02760160366.</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/0074-02760160366</ArticleId><ArticleId IdType="pmc">PMC5354609</ArticleId><ArticleId IdType="pubmed">28327786</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao X., Li W., Wang T., Ran D., Davalos V., Planas-Serra L., Pujol A., Esteller M., Wang X., Yu H. Accelerated biological aging in COVID-19 patients. Nat. Commun. 2022;13:2135. doi: 10.1038/s41467-022-29801-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-29801-8</ArticleId><ArticleId IdType="pmc">PMC9018863</ArticleId><ArticleId IdType="pubmed">35440567</ArticleId></ArticleIdList></Reference><Reference><Citation>Mabrey F.L., Morrell E.D., Wurfel M.M. TLRs in COVID-19: How they drive immunopathology and the rationale for modulation. J. Endotoxin Res. 2021;27:503–513. doi: 10.1177/17534259211051364.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/17534259211051364</ArticleId><ArticleId IdType="pmc">PMC8762091</ArticleId><ArticleId IdType="pubmed">34806446</ArticleId></ArticleIdList></Reference><Reference><Citation>Silva M.J.A., Silva C.S., Marinho R.L., Cabral J.G., Gurrão E.P.d.C., dos Santos P.A.S., Casseb S.M.M., Lima K.V.B., Lima L.N.G.C. Analysis of Epidemiological Factors and SNP rs3804100 of TLR2 for COVID-19 in a Cohort of Professionals Who Worked in the First Pandemic Wave in Belém-PA, Brazil. Genes. 2023;14:1907. doi: 10.3390/genes14101907.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/genes14101907</ArticleId><ArticleId IdType="pmc">PMC10606513</ArticleId><ArticleId IdType="pubmed">37895256</ArticleId></ArticleIdList></Reference><Reference><Citation>Elgedawy G.A., Elabd N.S., Salem R.H., Awad S.M., Amer A.A., Torayah M.M., El-Koa A.A., Abozeid M., Montaser B.A., Aboshabaan H.S., et al. FURIN, IFNL4, and TLR2 gene polymorphisms in relation to COVID-19 severity: A case–control study in Egyptian patients. Infection. 2024:1–7. doi: 10.1007/s15010-024-02266-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s15010-024-02266-1</ArticleId><ArticleId IdType="pubmed">38703289</ArticleId></ArticleIdList></Reference><Reference><Citation>Newell K.L., Clemmer D.C., Cox J.B., Kayode Y.I., Zoccoli-Rodriguez V., Taylor H.E., Endy T.P., Wilmore J.R., Winslow G.M. Switched and unswitched memory B cells detected during SARS-CoV-2 convalescence correlate with limited symptom duration. PLoS ONE. 2021;16:e0244855. doi: 10.1371/journal.pone.0244855.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0244855</ArticleId><ArticleId IdType="pmc">PMC7843013</ArticleId><ArticleId IdType="pubmed">33507994</ArticleId></ArticleIdList></Reference><Reference><Citation>Ait-Belkacem I., García C.C., Millet-Wallisky E., Izquierdo N., Loosveld M., Arnoux I., Morange P.-E., Galland F., Lambert N., Malergue F., et al. SARS-CoV-2 spike protein induces a differential monocyte activation that may contribute to age bias in COVID-19 severity. Sci. Rep. 2022;12:20824. doi: 10.1038/s41598-022-25259-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-25259-2</ArticleId><ArticleId IdType="pmc">PMC9716544</ArticleId><ArticleId IdType="pubmed">36460710</ArticleId></ArticleIdList></Reference><Reference><Citation>Landolina N., Ricci B., Veneziani I., Alicata C., Mariotti F.R., Pelosi A., Quatrini L., Mortari E.P., Carsetti R., Vacca P., et al. TLR2/4 are novel activating receptors for SARS-CoV-2 spike protein on NK cells. Front. Immunol. 2024;15:1368946. doi: 10.3389/fimmu.2024.1368946.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2024.1368946</ArticleId><ArticleId IdType="pmc">PMC11176535</ArticleId><ArticleId IdType="pubmed">38881905</ArticleId></ArticleIdList></Reference><Reference><Citation>Flores-Gonzalez J., Chavez-Galan L., Falfán-Valencia R., Roldán I.B., Fricke-Galindo I., Veronica-Aguilar A., Martínez-Morales A., Hernández-Zenteno R.d.J., Guzmán-Guzmán I.P., Pérez-Rubio G. Variant rs4986790 of toll-like receptor 4 affects the signaling and induces cell dysfunction in patients with severe COVID-19. Int. J. Infect. Dis. 2024;138:102–109. doi: 10.1016/j.ijid.2023.11.032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2023.11.032</ArticleId><ArticleId IdType="pubmed">38029833</ArticleId></ArticleIdList></Reference><Reference><Citation>ARDS Definition of Task Force. Ranieri V.M., Rubenfeld G.D., Thompson B.T., Ferguson N.D., Caldwell E., Fan E., Camporota L., Slutsky A.S. Acute Respiratory Distress Syndrome: The Berlin Definition. JAMA. 2012;307:2526–2533. doi: 10.1001/jama.2012.5669.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2012.5669</ArticleId><ArticleId IdType="pubmed">22797452</ArticleId></ArticleIdList></Reference><Reference><Citation>Kendall E.A., Tarique A.A., Hossain A., Alam M.M., Arifuzzaman M., Akhtar N., Chowdhury F., Khan A.I., LaRocque R.C., Harris J.B., et al. Development of immunoglobulin M memory to both a T-cell-independent and a T-cell-dependent antigen following in-fection with Vibrio cholerae O1 in Bangladesh. Infect. Immun. 2010;78:253–259. doi: 10.1128/IAI.00868-09.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/IAI.00868-09</ArticleId><ArticleId IdType="pmc">PMC2798198</ArticleId><ArticleId IdType="pubmed">19858296</ArticleId></ArticleIdList></Reference><Reference><Citation>Graffelman J., Jain D., Weir B. A genome-wide study of Hardy–Weinberg equilibrium with next generation sequence data. Hum. Genet. 2017;136:727–741. doi: 10.1007/s00439-017-1786-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00439-017-1786-7</ArticleId><ArticleId IdType="pmc">PMC5429372</ArticleId><ArticleId IdType="pubmed">28374190</ArticleId></ArticleIdList></Reference><Reference><Citation>Barrett J.C., Fry B., Maller J., Daly M.J. Haploview: Analysis and visualization of LD and haplotype maps. Bioinformatics. 2005;21:263–265. doi: 10.1093/bioinformatics/bth457.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/bth457</ArticleId><ArticleId IdType="pubmed">15297300</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>